<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">Regarding the body shape changes (BSC), 10/54 (18.5%) patients in the therapy Group A had clinical signs of lipodystrophy (Fig. 
 <xref rid="Fig3" ref-type="fig">3</xref>), compared to 3/53 patients (5.6%) untreated of Group B (p = 0.04) and in respect of group C (0/50, p = 0.0009).
</p>
